Label: FUNGINIX JOCK ITCH TREATMENT- tolnaftate cream

  • NDC Code(s): 71229-104-11
  • Packager: The Sisquoc Healthcare Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 31, 2023

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    TOLNAFTATE 1%

  • PURPOSE

    ANTIFUNGAL

  • USES

    • ANTI-FUNGAL TREATMENT
  • WARNINGS

    FOR EXTERNAL USE ONLY.

    DO NOT USE ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR.

    WHEN USING THIS PRODUCT AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS, RINSE THE EYES VERY THOROUGHLY WITH WATER.

    STOP USE AND ASK A DOCTOR IF IRRITATION OCCURS OR THERE IS NO IMPROVEMENT WITHIN 4 WEEKS.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

  • DIRECTIONS

    • For the cure of all forms of jock itch. For relief of itching, scaling, cracking, burning, redness, soreness, irritation and discomforts which may accompany these conditions. 
    • Wash affected area and dry thoroughly. Apply a layer of FUNGINIX Jock Itch Treatment over the affected area twice daily (morning and night). Allow the cream to dry for at least 3 minutes before covering the affected area with clothing. 
    • Wash hands after each application to prevent the chance of the infection spreading to other parts of the skin. 
    • Most jock itch infections will require at least 2 weeks of continuous daily treatment before the infection is completely eliminated. 
    • Proper use of FUNGINIX Jock Itch Treatment should eliminate all types of fungal infections. If the condition persists longer, contact a physician or medical professional.
  • INACTIVE INGREDIENTS

    Water, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Oleth-10 Phosphate, Triethanolamine, Polysorbate 20, Acrylates Copolymer, Glycerin,
    Propylene Glycol, Uva Ursi (Bearberry) Extract, Beta-Glucan, Propolis Extract, Aloe Barbadensis Juice, Tocopheryl Acetate (Vitamin E), Camphor, Menthol, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Lavandula Angustifolia (Lavender) Oil, Jasminum Oficinale (Jasmine) Oil, Eugenia Caryophyllus (Clove) Flower Oil, Theobroma Cacao (Cocoa) Seed Butter, Rosa Canina (Rose Hip) Flower Oil, Cetyl  Hydroxyethylcellulose, Ethylhexylglycerin, Phenoxyethanol

  • STORAGE AND HANDLING

    Store between 20°c to 25°C (68° to 77°F)

  • PRINCIPAL DISPLAY PANEL

    Label Proof Jock_Page_1

    Funginix JI Insert

  • INGREDIENTS AND APPEARANCE
    FUNGINIX JOCK ITCH TREATMENT 
    tolnaftate cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71229-104
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE1 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    ALMOND OIL (UNII: 66YXD4DKO9)  
    OLETH-10 PHOSPHATE (UNII: Q95361F4VS)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    BUTYL ACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID COPOLYMER (18000 MW) (UNII: JZ1374NL9E)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    ARCTOSTAPHYLOS UVA-URSI WHOLE (UNII: 37SXO36KR7)  
    OAT (UNII: Z6J799EAJK)  
    PROPOLIS WAX (UNII: 6Y8XYV2NOF)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    CAMPHOR OIL (UNII: 75IZZ8Y727)  
    MENTHOL (UNII: L7T10EIP3A)  
    TEA TREE OIL (UNII: VIF565UC2G)  
    LAVANDULA ANGUSTIFOLIA WHOLE (UNII: 51217XIL5L)  
    JASMINUM OFFICINALE WHOLE (UNII: X3314B4SYD)  
    CLOVE LEAF OIL (UNII: VCA5491KVF)  
    COCOA BUTTER (UNII: 512OYT1CRR)  
    ROSA CANINA FRUIT OIL (UNII: CR7307M3QZ)  
    CETYL HYDROXYETHYLCELLULOSE (350000 MW) (UNII: T7SWE4S2TT)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71229-104-1128 g in 1 TUBE; Type 0: Not a Combination Product03/25/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00503/25/2019
    Labeler - The Sisquoc Healthcare Corporation (021517142)